Spanish Red Biotech Pipeline

FUND. PROGRESO Y SALUD

FIBAO19007-20007 Use of BCL7A as molecular target for DLBCL drug screening & development

Type: Others
Therapeutic area: Blood and Lymphatic systems
Cancer
Indication: Diffuse large B cell lymphoma
Phase: 2Preclinical Validation, 1R+D
Studies location: SPAIN